prikaz prve stranice dokumenta Optimisation of breast cancer patients’ follow- up – potential way to improve cancer care in transitional countries.
Access restricted to all Croatian higher education institution's students and staff
Scientific paper - Original scientific paper
Optimisation of breast cancer patients’ follow- up – potential way to improve cancer care in transitional countries.
European Journal of Cancer Care, 26 (2017), 4; 12514-12520. https://doi.org/10.1111/ecc.12514
Bošković, Lidija; Gašparić, Maja; Petrić Miše, Branka; Petković, Marija; Gugić, Damir; Ban, Marija; Jazvić, Marijana; Dabelić, Nina; Belac-Lovasić, Ingrid; Vrdoljak, Eduard

Institutional repository: Repository of the University of Rijeka, Faculty of Medicine

Cite this document

Bošković, L., Gašparić, M., Petrić Miše, B., Petković, M., Gugić, D., Ban, M. ... Vrdoljak, E. (2017). Optimisation of breast cancer patients’ follow- up – potential way to improve cancer care in transitional countries.. European Journal of Cancer Care, 26. (4), 12514-12520. doi: 10.1111/ecc.12514

Bošković, Lidija, et al. "Optimisation of breast cancer patients’ follow- up – potential way to improve cancer care in transitional countries.." European Journal of Cancer Care, vol. 26, no. 4, 2017, pp. 12514-12520. https://doi.org/10.1111/ecc.12514

Bošković, Lidija, Maja Gašparić, Branka Petrić Miše, Marija Petković, Damir Gugić, Marija Ban, Marijana Jazvić, Nina Dabelić, Ingrid Belac Lovasić and Eduard Vrdoljak. "Optimisation of breast cancer patients’ follow- up – potential way to improve cancer care in transitional countries.." European Journal of Cancer Care 26, no. 4 (2017): 12514-12520. https://doi.org/10.1111/ecc.12514

Bošković, L., et al. (2017) 'Optimisation of breast cancer patients’ follow- up – potential way to improve cancer care in transitional countries.', European Journal of Cancer Care, 26(4), pp. 12514-12520. doi: 10.1111/ecc.12514

Bošković L, Gašparić M, Petrić Miše B, Petković M, Gugić D, Ban M, and sur.. Optimisation of breast cancer patients’ follow- up – potential way to improve cancer care in transitional countries.. European Journal of Cancer Care [Internet]. 2017 [cited 2024 May 13];26(4):12514-12520. doi: 10.1111/ecc.12514

L. Bošković, et al., "Optimisation of breast cancer patients’ follow- up – potential way to improve cancer care in transitional countries.", European Journal of Cancer Care, vol. 26, no. 4, pp. 12514-12520, 2017. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:950893. [Accessed: 13 May 2024]

Metadata
Title (english)Optimisation of breast cancer patients’ follow- up – potential way to improve cancer care in transitional countries.
AuthorLidija Bošković
AuthorMaja Gašparić
AuthorBranka Petrić Miše
AuthorMarija Petković
AuthorDamir Gugić
AuthorMarija Ban
AuthorMarijana Jazvić
AuthorNina Dabelić
AuthorIngrid Belac-Lovasić
AuthorEduard Vrdoljak
Author's institutionUniversity of Rijeka
Faculty of Medicine
(Department of Oncology and Radiotherapy)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Oncology
Abstract (english)
The aim of this analysis was to evaluate adherence of Croatian oncologists to follow‐up criteria as suggested by the current national and international guidelines for women with breast cancer receiving adjuvant endocrine therapy. The use of clinical and diagnostic methods was documented in this prospective, non‐interventional, multicenter study. A total of 438 post‐menopausal patients receiving adjuvant endocrine treatment with non‐steroidal aromatase inhibitors were included. Average annual frequency for each clinical and diagnostic method was calculated. Median adjuvant endocrine treatment duration before study recruitment was 10.5 months (interquartile 4.7–26.6). Patients were followed up for an average 23.5 ± 4.9 months. Average number of oncological visits was 5.3. Mammograms were performed at mean annual frequency of 0.7, chest radiographs at 0.5, abdominal ultrasounds at 0.9, breast ultrasounds at 1.2, complete blood counts and chemistry panels at 1.7, carcinoembryonic antigen at 0.8, cancer antigen 15‐3 at 1.6, gynaecological examination at 0.3, and densitometry at mean annual frequency of 0.3. In conclusion, among post‐menopausal women with breast cancer receiving adjuvant endocrine therapy in this study, more unnecessary and unproven follow‐up procedures were done compared to the guidelines' recommendations.
Keywords (english)
Languageenglish
Publication typeScientific paper - Original scientific paper
Publication statusPublished
Peer reviewPeer review - international
Publication versionPublished version
Journal titleEuropean Journal of Cancer Care
Numberingvol. 26, no. 4, pp. 12514-12520
p-ISSN0961-5423
e-ISSN1365-2354
DOIhttps://doi.org/10.1111/ecc.12514
URN:NBNurn:nbn:hr:184:950893
Publication2017
Document URLhttp://bib.irb.hr/999241
Type of resourceText
Access conditionsRestricted access
Terms of useLicence In copyright icon
Created on2022-03-01 13:29:43